• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经静脉导线拔除:当前方法与未来趋势。

Transvenous Lead Extractions: Current Approaches and Future Trends.

作者信息

Perez Adryan A, Woo Frank W, Tsang Darren C, Carrillo Roger G

机构信息

University of Miami Miller School of Medicine Miami, FL, USA.

Palmetto General Hospital Hialeah, FL, USA.

出版信息

Arrhythm Electrophysiol Rev. 2018 Aug;7(3):210-217. doi: 10.15420/aer.2018.33.2.

DOI:10.15420/aer.2018.33.2
PMID:30416735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6141917/
Abstract

The use of cardiac implantable electronic devices (CIEDs) has continued to rise along with indications for their removal. When confronted with challenging clinical scenarios such as device infection, malfunction or vessel occlusion, patients often require the prompt removal of CIED hardware, including associated leads. Recent advancements in percutaneous methods have enabled physicians to face a myriad of complex lead extractions with efficiency and safety. Looking ahead, emerging technologies hold great promise in making extractions safer and more accessible for patients worldwide. This review will provide the most up-to-date indications and procedural approaches for lead extractions and insight on the future trends in this novel field.

摘要

心脏植入式电子设备(CIEDs)的使用随着其移除指征的增加而持续上升。当面对诸如设备感染、故障或血管阻塞等具有挑战性的临床情况时,患者通常需要迅速移除CIED硬件,包括相关导联。经皮方法的最新进展使医生能够高效、安全地面对各种复杂的导联拔除。展望未来,新兴技术在使拔除对全球患者来说更安全、更容易方面具有巨大潜力。本综述将提供导联拔除的最新指征和操作方法,并深入探讨这一新兴领域的未来趋势。

相似文献

1
Transvenous Lead Extractions: Current Approaches and Future Trends.经静脉导线拔除:当前方法与未来趋势。
Arrhythm Electrophysiol Rev. 2018 Aug;7(3):210-217. doi: 10.15420/aer.2018.33.2.
2
Experience of cardiac implantable electronic device lead removal from a South African tertiary referral centre.南非一家三级转诊中心的心脏植入式电子设备导线移除经验。
Cardiovasc J Afr. 2021;32(4):193-197. doi: 10.5830/CVJA-2021-010. Epub 2021 Apr 19.
3
Transvenous extraction of permanent pacemaker and defibrillator leads: Reduced procedural complexity and higher procedural success rates in patients with infective versus noninfective indications.经静脉取出永久性心脏起搏器和除颤器导线:感染性与非感染性适应证患者中,操作复杂性降低且操作成功率更高。
J Cardiovasc Electrophysiol. 2021 Feb;32(2):491-499. doi: 10.1111/jce.14841. Epub 2020 Dec 25.
4
Comparison of standard and modified transvenous techniques for complex pacemaker lead extractions in the context of cardiac implantable electronic device-related infections: a 10-year experience.在心脏植入式电子设备相关感染的情况下,比较标准和改良的经静脉技术用于复杂起搏器导线拔除:一项 10 年经验。
Europace. 2013 Nov;15(11):1629-35. doi: 10.1093/europace/eut077. Epub 2013 Jul 25.
5
Transvenous lead extraction at the time of cardiac implantable electronic device upgrade: Complexity, safety, and outcomes.经静脉心脏植入式电子设备升级时的导线拔除术:复杂性、安全性和结果。
Heart Rhythm. 2017 Dec;14(12):1807-1811. doi: 10.1016/j.hrthm.2017.08.019. Epub 2017 Aug 23.
6
Outcomes of cardiac implantable electronic device transvenous lead extractions performed in centers without onsite cardiac surgery.无心脏外科手术条件中心经静脉心脏植入式电子装置导线拔除术的结果。
Int J Cardiol. 2020 Feb 1;300:154-160. doi: 10.1016/j.ijcard.2019.07.095. Epub 2019 Aug 5.
7
Transvenous Extraction and Removal of Pacing Leads Placed after Cardiac Transplantation.经静脉取出心脏移植术后置入的起搏导线
Case Rep Cardiol. 2019 Jan 3;2019:6270950. doi: 10.1155/2019/6270950. eCollection 2019.
8
Overcoming the current issues surrounding device leads: reducing the complications during extraction.克服当前围绕设备导线的问题:减少拔除过程中的并发症。
Expert Rev Med Devices. 2017 Jun;14(6):469-480. doi: 10.1080/17434440.2017.1332990.
9
Cardiac lead management: the future of transvenous lead extraction approaches and technologies.心脏导线管理:经静脉导线拔除方法与技术的未来。
Minerva Cardioangiol. 2018 Feb;66(1):100-112. doi: 10.23736/S0026-4725.17.04466-8. Epub 2017 Jul 10.
10
Anesthetic Management of Laser Lead Extraction for Cardiovascular Implantable Electronic Devices.心血管植入式电子设备激光导线拔除术的麻醉管理
Semin Cardiothorac Vasc Anesth. 2017 Dec;21(4):302-311. doi: 10.1177/1089253217728581. Epub 2017 Sep 21.

引用本文的文献

1
Transvenous lead extraction: Experience from a Northern State of India - The Srinagar extraction registry.经静脉导线拔除术:来自印度北部一个邦的经验——斯利那加拔除登记处
Indian Pacing Electrophysiol J. 2025 Mar-Apr;25(2):58-66. doi: 10.1016/j.ipej.2025.03.002. Epub 2025 Mar 7.
2
Extraction of His Bundle Pacing Lead: More Difficult than Coronary Sinus Lead Extraction: An Analysis of 3897 Lead Extraction Procedures Including 27 His and 253 Coronary Sinus Lead Removals.希氏束起搏导线拔除:比冠状窦导线拔除更困难:对3897例导线拔除手术的分析,包括27例希氏束导线和253例冠状窦导线拔除。
Biomedicines. 2024 May 23;12(6):1154. doi: 10.3390/biomedicines12061154.
3
Evaluation of a compact 3 T MRI scanner for patients with implanted devices.评估一款用于植入式设备患者的紧凑型 3T MRI 扫描仪。
Magn Reson Imaging. 2023 Nov;103:109-118. doi: 10.1016/j.mri.2023.07.009. Epub 2023 Jul 17.
4
Practical Approaches to Transvenous Lead Extraction Procedures-Clinical Case Series.经静脉导线拔除术的实用方法-临床病例系列。
Int J Environ Res Public Health. 2022 Dec 26;20(1):379. doi: 10.3390/ijerph20010379.
5
Transvenous Lead Extraction Procedure-Indications, Methods, and Complications.经静脉导线拔除术——适应证、方法及并发症
Biomedicines. 2022 Nov 1;10(11):2780. doi: 10.3390/biomedicines10112780.
6
Transvenous lead extraction in conduction system pacing.传导系统起搏中的经静脉导线拔除术。
Front Physiol. 2022 Aug 11;13:993604. doi: 10.3389/fphys.2022.993604. eCollection 2022.
7
An Unusual Cause of Cerebral Embolism: PFO-Straddling, Spontaneously Fractured Pacemaker Lead.脑栓塞的一个不寻常原因:卵圆孔未闭跨隔、自发断裂的起搏器导线。
JACC Case Rep. 2022 Jul 20;4(14):854-856. doi: 10.1016/j.jaccas.2022.05.003.
8
Evaluation of a novel mechanical compression device for hematoma prevention and wound cosmesis after CIED implantation.评估一种新型机械压迫装置在预防 CIED 植入后血肿和伤口美容方面的效果。
Pacing Clin Electrophysiol. 2022 Apr;45(4):491-498. doi: 10.1111/pace.14454. Epub 2022 Mar 4.
9
A 37-Year-Old Woman with Hypertrophic Cardiomyopathy with a Dual-Chamber Implantable Cardioverter-Defibrillator Requiring Percutaneous Transvenous Lead Extraction and Multidisciplinary Management.一位 37 岁女性,患有肥厚型心肌病,合并使用双腔植入式心律转复除颤器,需要行经皮经腔静脉心脏电复律除颤器导线拔除术和多学科管理。
Am J Case Rep. 2021 Oct 22;22:e932073. doi: 10.12659/AJCR.932073.
10
Procedural outcome of lead explant and countertraction-assisted femoral lead extraction in Thai patients with cardiac implantable electronic device infection.泰国心脏植入式电子设备感染患者的导线取出及对抗牵引辅助股静脉导线取出的手术结果
J Arrhythm. 2021 Aug 5;37(5):1124-1130. doi: 10.1002/joa3.12574. eCollection 2021 Oct.

本文引用的文献

1
Strategies for Transvenous Lead Extraction Procedures.经静脉导线拔除术的策略
J Innov Card Rhythm Manag. 2017 May 15;8(5):2702-2716. doi: 10.19102/icrm.2017.080502. eCollection 2017 May.
2
Transvenous lead extraction during uninterrupted warfarin therapy: Feasibility and outcomes.经静脉导线拔除术在持续华法林治疗期间的可行性和结果。
Heart Rhythm. 2018 Dec;15(12):1777-1781. doi: 10.1016/j.hrthm.2018.07.018. Epub 2018 Aug 17.
3
Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).接受皮下或经静脉自动心脏除颤器植入术患者的围手术期常规、植入技术和与手术相关的并发症:欧洲皮下 ICD 植入术快照调查(ESSS-SICDI)的结果。
Europace. 2018 Jul 1;20(7):1218-1224. doi: 10.1093/europace/euy092.
4
Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.皮下与经静脉植入式心脏除颤器治疗:病例对照研究的荟萃分析。
JACC Clin Electrophysiol. 2017 Dec 26;3(13):1475-1483. doi: 10.1016/j.jacep.2017.07.017. Epub 2017 Sep 27.
5
2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS.2018年欧洲心律协会(EHRA)关于导线拔除的专家共识声明:临床科学研究和注册登记的定义、终点、研究试验设计及数据收集要求的建议:得到亚太心脏节律学会(APHRS)/美国心律学会(HRS)/拉丁美洲心脏节律学会(LAHRS)认可。
Europace. 2018 Jul 1;20(7):1217. doi: 10.1093/europace/euy050.
6
Incidence and Predictors of Perioperative Complications With Transvenous Lead Extractions: Real-World Experience With National Cardiovascular Data Registry.经静脉导线拔除术围手术期并发症的发生率及预测因素:国家心血管数据注册中心的真实世界经验。
Circ Arrhythm Electrophysiol. 2018 Feb;11(2):e004768. doi: 10.1161/CIRCEP.116.004768. Epub 2018 Feb 16.
7
The role of transvenous lead extraction in the management of redundant or malfunctioning pacemaker and defibrillator leads post ELECTRa.ELECTRa 后经静脉导线拔除术在处理冗余或故障的起搏器和除颤器导线中的作用。
Europace. 2018 Nov 1;20(11):1733-1740. doi: 10.1093/europace/euy018.
8
Midterm Safety and Performance of a Leadless Cardiac Pacemaker: 3-Year Follow-up to the LEADLESS Trial (Nanostim Safety and Performance Trial for a Leadless Cardiac Pacemaker System).无导线心脏起搏器的中期安全性和性能:LEADLESS试验(无导线心脏起搏器系统的Nanostim安全性和性能试验)的3年随访
Circulation. 2018 Feb 6;137(6):633-635. doi: 10.1161/CIRCULATIONAHA.117.030106.
9
Lead Management and Lead Extraction.潜在客户管理与潜在客户挖掘
Card Electrophysiol Clin. 2018 Mar;10(1):127-136. doi: 10.1016/j.ccep.2017.11.013.
10
Cost-effectiveness of TYRX absorbable antibacterial envelope for prevention of cardiovascular implantable electronic device infection.TYRX可吸收抗菌包膜预防心血管植入式电子设备感染的成本效益
J Med Econ. 2018 Mar;21(3):294-300. doi: 10.1080/13696998.2017.1409227. Epub 2018 Jan 3.